Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT00990600 Completed - HIV Infections Clinical Trials

QoL and Adherence to One-pill Once-a-day HAART

ADONE
Start date: April 2008
Phase: Phase 3
Study type: Interventional

Primary objective of the study is: To verify if simplification of the antiretroviral regimen, measured as the reduction of pill burden alone, may affect adherence rate of patients.

NCT ID: NCT00990392 Withdrawn - Clinical trials for Skin Diseases, Infectious

Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections

ToPICL
Start date: November 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if the overall central venous catheter related infection rate can be reduced by the application of Polysporin Triple Therapy ointment to the insertion site.

NCT ID: NCT00989144 Completed - HIV Infections Clinical Trials

Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort

SEARCH004
Start date: January 2007
Phase: N/A
Study type: Observational

The study of early, acute HIV infection is critical to understanding subtype-specific pathophysiologic differences, since up to 50% of acute HIV infections may be incapacitating. This study will establish whether the patient population of the Thai Red Cross Anonymous Clinic is suitable for the study of early, acute infection.

NCT ID: NCT00987402 Completed - Clinical trials for Postoperative Wound Infection

Study of the Efficacy of Plain Soap and Water Versus Alcohol-based Rubs for Surgical Hand Preparation

Start date: January 2007
Phase: Phase 1/Phase 2
Study type: Interventional

Surgical site infections (SSI) constitute a significant health-economic and clinical challenge. The investigators conducted a cluster-randomized, cross-over study to compare the efficacy of plain soap and water (PSW), used ubiquitously across sub-Saharan Africa for surgical hand preparation, to alcohol-based hand rub (ABHR), with SSI rates as the main outcome measure. A total of 3317 patients undergoing clean and clean-contaminated surgery were included in the study and followed up for 30 days.

NCT ID: NCT00986791 Completed - Clinical trials for Postoperative Complications

Alcohol Cessation Intervention in an Acute Surgical Setting

Start date: May 2010
Phase: N/A
Study type: Interventional

Hazardous alcohol intake is an independent risk factor for postoperative complications after major and minor operations, elective and emergency procedures for men and women. The aim of this study is to evaluate the effect of a 6-week Gold Standard Programme for alcohol cessation intervention in the perioperative period compared to the daily routine guidelines for patients with hazardous alcohol intake undergoing ankle fracture surgery.

NCT ID: NCT00985608 Recruiting - Clinical trials for Helicobacter Pylori Infection

Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study

Start date: April 2009
Phase: Phase 2
Study type: Interventional

H pylori gastric infection is one of the most prevalent infectious diseases worldwide. The discovery that most upper gastrointestinal diseases are related to H pylori infection and therefore can be treated with antibiotics is an important medical advance. Currently, a first-line triple therapy based on proton pump inhibitor (PPI) or ranitidine bismuth citrate (RBC) plus two antibiotics (clarithromycin and amoxicillin or nitroimidazole) is recommended by all consensus conferences and guidelines. Even with the correct use of this drug combination, infection can not be eradicated in up to 23% of patients. Therefore, several second line therapies have been recommended. A 7 d quadruple therapy based on PPI, bismuth, tetracycline and metronidazole is the more frequently accepted. However, with second-line therapy, bacterial eradication may fail in up to 40% of cases. When H pylori eradication is strictly indicated the choice of further treatment is controversial. When available, endoscopy with culture and consequent antibiotic susceptibility testing remains the most appropriate option for patients with two eradication failures to avoid a widespread use of expensive antibiotics. The use of these drugs may also induce severe side-effects and development of H pylori resistant strains. Resistant strains of Helicobacter pylori can display a dense biofilm with mucus and microorganisms in a coccoid shape on the mucosal surface of stomach that may have a role in determining the resistance to the antibiotic therapies. Possibly, N-acetil-cysteine (NAC) may dissolve biofilm architecture and help to eradicate resistant strains of H pylori.

NCT ID: NCT00984945 Completed - Clinical trials for Respiratory Tract Infections

Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

Start date: September 2009
Phase: Phase 1
Study type: Interventional

The primary objective is to assess the safety and tolerability of two consecutive doses of plant-based H5 VLP, (H5N1) pandemic influenza vaccine combined with Alhydrogel®, given 21 days apart, at three dose levels: 5µg, 10µg and 20µg., compared to the placebo, and combined with Alhydrogel®.

NCT ID: NCT00982189 Completed - HIV Infection Clinical Trials

Cardiovascular Prevention for Persons With HIV

Start date: September 2009
Phase: N/A
Study type: Interventional

This study is funded by the American Heart Association. The goal of this research is to prevent early cardiovascular damage before symptoms develop for persons with HIV infection. Evidence suggests that taking low doses of blood pressure and cholesterol medication reduces risk for heart disease in persons who are at increased risk (such as the case with HIV infection). Participants who are taking HIV treatment with an 'undetectable' viral load, and who do NOT need treatment for high blood pressure or cholesterol may be eligible to enroll. Participants will take a low dose cholesterol medication (or placebo) and a low dose of a blood pressure medication (or a placebo), and will be seen at 3 study visits over 4 months.

NCT ID: NCT00981513 Completed - Clinical trials for Acute Respiratory Infection

Direct and Indirect Benefits of Influenza Vaccination in Schools and Households

Start date: September 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the degree of indirect benefits to family members and classmates resulting from administration of influenza vaccine to children.

NCT ID: NCT00981279 Completed - HIV Infections Clinical Trials

Profile of HIV Seropositive Patients

PHSP
Start date: June 2009
Phase: N/A
Study type: Observational

The aim of this study was to delineate the epidemiological profile of HIV seropositive patients on antiretroviral therapy at the Clinical Hospital of the Federal University of Goiás.